Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Contrast Media Market, by Product Type
1.4.2 North America Contrast Media Market, by Application
1.4.3 North America Contrast Media Market, by Modality
1.4.4 North America Contrast Media Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : Sep, 2019–Mar, 2015) Leading Players
Chapter 4. North America Contrast Media Market by Product Type
4.1 North America Iodinated Market by Country
4.2 North America Barium-based Market by Country
4.3 North America Gadolinium-based Market by Country
4.4 North America Microbubble Market by Country
Chapter 5. North America Contrast Media Market by Application
5.1 North America Neurological disorders Market by Country
5.2 North America Cancer Market by Country
5.3 North America Cardiovascular disorders Market by Country
5.4 North America Gastrointestinal disorders Market by Country
5.5 North America Nephrological disorders Market by Country
5.6 North America Musculoskeletal disorders Market by Country
5.7 North America Other Applications Market by Country
Chapter 6. North America Contrast Media Market by Modality
6.1 North America X-ray/CT Market by Country
6.2 North America MRI Market by Country
6.3 North America Ultrasound Market by Country
Chapter 7. North America Contrast Media Market by Country
7.1 USA Contrast Media Market
7.1.1 USA Contrast Media Market by Product Type
7.1.2 USA Contrast Media Market by Application
7.1.3 USA Contrast Media Market by Modality
7.2 Canada Contrast Media Market
7.2.1 Canada Contrast Media Market by Product Type
7.2.2 Canada Contrast Media Market by Application
7.2.3 Canada Contrast Media Market by Modality
7.3 Mexico Contrast Media Market
7.3.1 Mexico Contrast Media Market by Product Type
7.3.2 Mexico Contrast Media Market by Application
7.3.3 Mexico Contrast Media Market by Modality
7.4 Rest of North America Contrast Media Market
7.4.1 Rest of North America Contrast Media Market by Product Type
7.4.2 Rest of North America Contrast Media Market by Application
7.4.3 Rest of North America Contrast Media Market by Modality
Chapter 8. Company Profiles
8.1 Bayer AG
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.5.2 Approvals:
8.2 General Electric (GE) Co. (GE Healthcare)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 The Guerbet Group
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.3.5.3 Product Launches and Product Expansions:
8.4 Lantheus Holdings, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.5 Bracco S.p.A.
8.5.1 Company Overview
8.5.2 Regional Analysis
8.5.3 Recent strategies and developments:
8.5.3.1 Product Launches and Product Expansions:
8.5.3.2 Acquisition and Mergers:
8.5.3.3 Approvals:
8.6 Trivitron Healthcare Pvt. Ltd.
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Partnerships, Collaborations, and Agreements:
8.7 Nano Therapeutics Pvt. Ltd.
8.7.1 Company Overview
8.8 Magnus Health, LLC (Veracross LLC)
8.8.1 Company Overview
8.9 Imax Diagnostic Imaging Limited
8.9.1 Company Overview
8.1 Daiichi Sankyo Company, Limited
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expense
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
Unique Offerings 